Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Startanja GmbH was a German holding company based in Munich that specialized in the acquisition and development of technology-driven businesses, particularly in the life sciences and healthcare sectors. The company gained prominence in 2009 when it acquired a controlling interest in Applied Digital Technologies (ADTI), a firm specializing in biometric medical records and emergency response systems. Startanja's business model involved identifying undervalued technologies with high growth potential and bridging US-based innovations with European marketing channels. The company was managed by Reinhard Proksch and operated as a private investment vehicle. It is currently inactive, having been dissolved or liquidated according to corporate registry records.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Startanja.